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An 8-year-old, spayed female Domestic Short-haired cat was referred for further evaluation 
of chronic lymphocytic–plasmacytic stomatitis and bilateral ocular disease. The cat 
had been treated with systemic glucocorticoids for several months. Initial ophthalmic 
examination revealed bilateral deep stromal corneal ulcers, exudative panuveitis and 
secondary glaucoma. Mature mild neutrophilia and monocytosis were detected on complete 
blood cell count. Abnormalities in the serum profile were hyperglycemia, mild azotemia, 
hyperglobulinemia and moderate polyclonal gammapathy. Urinalysis revealed glucosuria 
without ketonuria. Diabetes mellitus was diagnosed and treatment with long-acting insulin 
was started. An enzyme-linked immunosorbent assay was highly positive for leishmaniasis, 
and treatment with allopurinol was started. Although specific topical treatment was applied, 
melting ulcers progressed to corneal perforation and both eyes were enucleated. Ocular 
histology showed large numbers of intracellular organisms compatible with amastigotes 




 located in the uveal tract, cornea, sclera and retina. Results of 














 were positive. Three 
weeks later, hypoglycemic episodes permitted withdrawal of the insulin therapy. To the 
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An 8-year-old spayed female Domestic Short-haired cat weigh-
ing 2.9 kg was referred to the Veterinary Teaching Hospital
of the Autonomous University of Barcelona (HCV-UAB) for
further evaluation of chronic proliferative stomatitis and bilateral
corneal ulcer. The referring veterinarian had diagnosed chronic
lymphocytic–plasmacytic stomatitis by means of histopathologic
evaluation of oral biopsies, 8 months prior to referral. At that
time, results of serum biochemical profile and complete blood
cell count (CBC) were within normal limits, and enzyme-linked
immunosorbent assay (ELISA) results for FeLV and FIV were
negative. The stomatitis was treated with dental cleaning,
tolfenamic acid (4 mg/kg, PO, every 24 h; Tolfedine, Vetoquinol
s.a, Cedex, France), and enrofloxacin (5 mg/kg, subcutaneously,
every 24 h; Baytril, Bayer, Barcelona, Spain) for 10 days. Owing
to relapse of clinical signs, methylprednisolone acetate (20 mg/
cat intramuscularly; Depomoderin, Pharmacia Upjohn,
Barcelona, Spain) was added to the treatment, once weekly
for 8 months.
One month prior to referral, the cat was re-evaluated for
ocular disease. Bilateral anterior uveitis, fever and weight loss




 was 1 : 50 (reference range < 1 : 40). Treat-
ment was initiated with clindamycin (25 mg/kg, PO, every
12 h; Dalacín, Pharmacia, Barcelona, Spain) and topical
chloramphenicol–dexamethasone (one drop, OU, every 6 h;
Colircusí cloranfenicol and Maxidex; Alcon Cusí, Barcelona,
Spain). One week later the ocular condition had not improved
and deep stromal ulceration was detected OS. Topical cortico-
steroids were withdrawn and atropine topical ointment (one
application, OS, every 12 h; Oftalmolosa cusí atropine, Alcon
Cusí) was added to the treatment regimen. CBC and biochem-









































































L) and hypergammaglobulinemia (34 g/L; reference
range, 12–32 g/L) were found. The cat was then referred to
the HCV-UAB.
At the time of referral, the cat was slightly depressed, thin
and had poor hair coat quality. Other abnormalities detected





C), mild dehydration, distended cranial abdomen,
hepatomegaly, moderate diffuse gingivitis and marked
bilateral proliferative faucitis. Initial ophthalmic examination
revealed moderate blepharospasm, and severe mucoid dis-
charge OU. Menace response and dazzle reflex were absent
in both eyes. Pupillary light reflexes (PLRs) could not be
evaluated OU. Schirmer tear test was normal OU. Diffuse
transillumination and slit lamp biomicroscopic examination
OU (Kowa SL-14, Kowa Company, Tokyo, Japan) indicated
moderate scleral injection, chemosis, deep stromal corneal
ulceration, and diffuse endothelial corneal edema OU (Fig. 1).
Both eyes presented with severe aqueous flare (+4). Intraocular
pressure (IOP) measurements obtained by applanation
tonometry (Tonopen XL, Mentor, Norwell, MA, USA)
following instillation of topical anesthetic (Tetracaine
hydrochloride 0.5%, Alcon-Cusí) were 35 mmHg OD
and 32 mmHg OS. The lens and fundus could not be evalu-
ated OU. At this point, deep stromal corneal ulceration
and exudative panuveitis with secondary glaucoma were
diagnosed OU.



















































L). Abnormalities on the serum profile were
hyperglycemia (354 mg/dL; reference range, 73–134 mg/
dL), mild azotemia (70 mg/dL; reference range, 42–64 mg/
dL), hyperglobulinemia (5.32 mg/dL; reference range, 3.3–
4.5 mg/dL) and polyclonal gammopathy (2.4 mg/dL; refer-
ence range, 1.3–2.2 mg/dL). Urinalysis abnormalities were
glucosuria without ketonuria.
Based on the medical history, physical examination and
laboratory test results, the most likely differential diagnoses
included reactive hepatopathy due to diabetes mellitus (DM),
colangiohepatitis complex, lymphoma, feline infectious perito-
nitis (FIP), FeLV, FIV, systemic mycosis, bartonellosis, leish-
maniasis, herpesvirus infection and ehrlichiosis.
Additional diagnostic tests included abdominal and thoracic
radiographs, abdominal ultrasonography, hepatic fine-needle























]. Abdominal radiographs and ultrasonography
demonstrated a diffusely enlarged liver with diffuse hyper-
echogenicity. Microscopic examination of hepatic FNA yielded
normal hepatocytes and neutrophils. Persistence of hyper-
glycemia and glucosuria was detected. Type III DM (probably
associated with long-term glucocorticoid administration)
and bilateral panuveitis with stromal corneal ulcer were
diagnosed. Systemic glucocorticoids were withdrawn and
the suspected type III DM was managed with long-acting
insulin (0.5 U/kg subcutaneously, every 12 h; Humulina
ultralenta, Lilly) and clindamycin (25 mg/kg intravenously,
every 12 h; Dalacín Pharmacia). Ophthalmic treatment
consisted of topical oxytetracycline (one drop, OU, every 6 h
(Colircusí aureomicina, Alcon Cusí), atropine ointment
(one application, OU, every 12 h; Oftalmolosa cusí atropina,
Alcon Cusí), flurbiprofen (one drop, OU, every 6 h; Ocuflur,
Allergan) and dorzolamide (one drop, OU, every 8 h; Trusopt;
Merck, Sharp and Dohme Chibret, Madrid, Spain).
One week after initial presentation, the cat was re-evaluated.
It had increased 0.4 kg in body weight, but was mentally
depressed and the ocular condition had worsened. On
ophthalmic examination, bilateral melting keratitis with deep
stromal ulceration was present. Corneal cytology showed
epithelial corneal cells and neutrophils, but no bacteria or
parasites were observed. At this point, ELISA serum titers
results were highly positive for leishmaniasis (300%; normal
range < 40%), slightly positive for toxoplasmosis (1 : 50;
reference range < 1 : 40) and FeCoV (1 : 340; reference range




 (1 : 20; reference range





 A presumptive diagnosis of feline leishmaniasis
and DM was made. The cat was managed with allopurinol
(10 mg/kg, PO, every 12 h; Zyloric, Faes Laboratories, Vizcaya,
Spain); long-acting insulin (same dose), cephalexin (20 mg/
kg, intravenously, every 8 h; Kefloridina; Lilly Laboratories,
Madrid, Spain); tobramycin (one drop, OU, every 1 h; Tobrex;
Alcon Cusí); flurbiprofen (one drop, OU, every 8 h; Ocuflur,
Allergan, Madrid, Spain); feline serum (one drop, OU, every
1 h) and atropine ointment (one application, OU, every
12 h; Oftalmolosa cusi atropine, Alcon Cusí). Melting
keratitis progressed to corneal perforation OU within a few
hours. At this point, corneal graft and conjunctival flap was
recommended, but due to the poor ocular prognosis, the
owner decided to have a bilateral enucleation performed.
Two days after admission, bilateral enucleation and bone
marrow aspiration from the iliac crest were performed. The
cat was discharged 2 days after surgery with allopurinol (same
dose), long-acting insulin (same dose), and enrofloxacin
(5 mg/kg, PO, every 24 h, for 10 days; Baytril, Bayer).
Ocular histopathology of the enucleated eyes demonstrated
a granulomatous inflammation located in fibrous and vascular
layers with large number of intracellular organisms compatible




(Figs 2 and 3).
Inmunohistochemistry staining of ocular tissues confirmed




 parasites (Fig. 4). Bone marrow










 was positive. Therapy with allopurinol
and long-acting insulin was maintained.
One month later the cat had gained 0.6 kg in body weight,
still had glucosuria and signs referable to oral discomfort were
waning and waxing. Three weeks later, several hypoglycemic
episodes made withdrawal of the insulin therapy necessary.
 














Three months later, CBC and biochemical profile revealed
mild polyclonal gammapathy (32 g/L reference range, 12–
32 g/L) and a decrease in the leishmaniosis titer (140%). Nine
months after the diagnosis, the cat was clinically healthy despite
the fact that the owners had stopped allopurinol therapy
3 months earlier. CBC and biochemical profile revealed
moderate polyclonal gammapathy (38 g/L, reference range,
12–32 g/L) and serum leishmaniasis titer result was higher




Leishmaniasis is a worldwide infectious disease of people and





. It is a frequent cause of clinical disease in dogs





infection appears to be rare in the cat. Since 1911 about 50





prevalence of feline leishmaniasis in endemic areas could be




However, in endemic areas there is a high possibility of infection.









 In some reports, feline leishmaniasis was





 although this association has not been confirmed.
It is important to include leishmaniasis in the differential
Figure 1. Right eye. Note the mucoid discharge, chemosis and diffuse 
endothelial corneal edema. The stromal corneal ulceration is behind 
the nictitating membrane.
Figure 2. Histopathology of the right globe. Note the central corneal 
perforation, exudate in anterior chamber and vitreous. Hematoxlyn 
and eosin. Bar = 2000 µm.
Figure 3. Macrophagic cells containing numerous amastigote forms of 
Leishmania species in the uveal tract. Hematoxlyn and eosin. Bar = 20 µm.
Figure 4. Choroidal immunohistochemistry for detection of 
























diagnosis of immunodeficient cats with systemic disease
and polyclonal gammopathy. In our case, FIV and FeLV
infection were ruled out, but as the patient was treated with














anterior uveitis is the most ocular common finding and may




 Melting ulcers, although
not frequent, are a complicating component of corneal ulcer.
Corneal epithelial cells, fibroblasts, polymorphonuclear
leukocytes, some bacterias and possibly fungi produce an
abnormal amount of proteases and collagenases that contributed





 In this case, histopathology confirmed the presence




 amastigotes and leukocytes





 amastigotes or by polymorphonuclear




has not been proven. To the authors’ knowledge this is the
second description of panuveitis due to feline leishmaniasis,
but it is the first with associated melting keratitis. In endemic
areas, leishmaniasis should be included in differential diagnosis
of feline uveitis and corneal melting ulcers.
Diagnosis of feline leishmaniasis is difficult because serology
and serum protein electrophoresis patterns are generally




 In doubtful cases,
immunohistochemical staining techniques and PCR analysis




 identification. In the case




 titer was positive and bone


















 species could not be




 was suspected, due to its




 Some previous studies









 In this report, ocular
leishmaniasis was diagnosed by means of immunohistochemistry
on ocular tissues examined after bilateral enucleation.
Type III or secondary DM was the most likely cause of
hyperglycemia. This type of DM has been associated with
hyperadrenocorticism, hyperthyroidism, excessive growth





 In this case, DM could be the
result of administering high doses of long-acting glucocor-
ticoids for several months. Insulin therapy and/or gradual
tapering of glucocorticoid treatment allowed good control
of blood glucose. Persistent hyperglycemia is an important
factor in cats inducing glucose toxicity phenomena and inhi-





starting insulin treatment and withdrawal of glucocorticoids,
secretion of insulin is re-established and hypoglycemic crises
can occur. In this case, hypoglycemia episodes occurred
2 months after the initiation of therapy, and insulin treatment
was stopped without any further observed relapses.
Owing to the small number of reported cases, feline leish-
maniasis treatment is not defined. In this case, treatment





initiated and the clinical state of the patient improved as well




 titer also decreased
with the treatment. Interestingly, the serum titer along with
the polyclonal gammopathy increased again after the owner
stopped the medication. Combining the treatments of the
predisposing cause (when it is known) together with allopurinol
seemed to be a good therapeutic option in this case.
To the authors’ knowledge, this is the first case of visceral




 with favorable response




The cat was treated at the Veterinary Teaching Hospital,
Facultat the Veterinària, Universitat Autònoma de Barcelona.
We thank our colleagues from Novavet Veterinary Clinic for
referring the case and our colleagues from the Pathology
Department for performing the histopathologic studies.
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